Literature DB >> 26819057

Pegylated interferon alpha-2a for essential thrombocythemia during pregnancy: outcome and safety. A case series.

Yan Beauverd1, Deepti Radia1, Catherine Cargo2, Steve Knapper3, Mark Drummond4, Arvind Pillai5, Claire Harrison1, Susan Robinson6.   

Abstract

Entities:  

Keywords:  essential thrombocythemia; outcomes; pegylated interferon; pregnancy; safety

Mesh：

Substances：

Year:  2016        PMID： 26819057      PMCID： PMC5004380          DOI： 10.3324/haematol.2015.139691

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  16 in total

1.  A phase II trial of pegylated interferon alpha-2b therapy for polycythemia vera and essential thrombocythemia: feasibility, clinical and biologic effects, and impact on quality of life.

Authors:  Jan Samuelsson; Hans Hasselbalch; Oystein Bruserud; Snezana Temerinac; Yvonne Brandberg; Mats Merup; Olle Linder; Magnus Bjorkholm; Heike L Pahl; Gunnar Birgegard
Journal:  Cancer       Date:  2006-06-01       Impact factor: 6.860

2.  Impact of mutational status on pregnancy outcome in patients with essential thrombocytemia.

Authors:  Elisa Rumi; Irene Bertozzi; Ilaria C Casetti; Elisa Roncoroni; Chiara Cavalloni; Marta Bellini; Emanuela Sant'Antonio; Manuel Gotti; Virginia V Ferretti; Chiara Milanesi; Edoardo Peroni; Daniela Pietra; Cesare Astori; Maria Luigia Randi; Mario Cazzola
Journal:  Haematologica       Date:  2015-08-06       Impact factor: 9.941

3.  A long-term retrospective study of young women with essential thrombocythemia.

Authors:  A Tefferi; R Fonseca; D L Pereira; H C Hoagland
Journal:  Mayo Clin Proc       Date:  2001-01       Impact factor: 7.616

4.  Pegylated interferon for the treatment of high risk essential thrombocythemia: results of a phase II study.

Authors:  Christian Langer; Eva Lengfelder; Jürgen Thiele; Hans M Kvasnicka; Heike L Pahl; Heimo Beneke; Stefanie Schauer; Heinz Gisslinger; Martin Griesshammer
Journal:  Haematologica       Date:  2005-10       Impact factor: 9.941

5.  Aspirin use during early pregnancy and the risk of congenital abnormalities: a population-based case-control study.

Authors:  Bente Nørgård; Erzsébet Puhó; Andrew E Czeizel; Mette V Skriver; Henrik T Sørensen
Journal:  Am J Obstet Gynecol       Date:  2005-03       Impact factor: 8.661

6.  Outcome of 122 pregnancies in essential thrombocythemia patients: A report from the Italian registry.

Authors:  Lorella Melillo; Alessia Tieghi; Anna Candoni; Franca Radaelli; Rosanna Ciancia; Giorgina Specchia; Bruno Martino; Potito Rosario Scalzulli; Roberto Latagliata; Fausto Palmieri; Emilio Usala; Daniela Valente; Maria Rosa Valvano; Michele Cedrone; Giuseppina Comitini; Vincenzo Martinelli; Nicola Cascavilla; Luigi Gugliotta
Journal:  Am J Hematol       Date:  2009-10       Impact factor: 10.047

Review 7.  Management of Philadelphia negative chronic myeloproliferative disorders in pregnancy.

Authors:  Martin Griesshammer; Sabine Struve; Tiziano Barbui
Journal:  Blood Rev       Date:  2008-07-09       Impact factor: 8.250

8.  Infant of 22 months of age with no anomalies born from a HCV- and HIV-infected mother under treatment with pegylated interferon, ribavirin and antiretroviral therapy during the first 16 weeks of pregnancy.

Authors:  Pablo Labarga; Javier Pinilla; Iban Cachorro; Yolanda Ruiz; Yolanda Ruiz del Prado
Journal:  Reprod Toxicol       Date:  2007-07-07       Impact factor: 3.143

9.  Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation.

Authors:  Francesco Passamonti; Maria Luigia Randi; Elisa Rumi; Ester Pungolino; Chiara Elena; Daniela Pietra; Margherita Scapin; Luca Arcaini; Fabiana Tezza; Remigio Moratti; Cristiana Pascutto; Fabrizio Fabris; Enrica Morra; Mario Cazzola; Mario Lazzarino
Journal:  Blood       Date:  2007-04-10       Impact factor: 22.113

10.  Predictors of pregnancy outcome in essential thrombocythemia: a single institution study of 63 pregnancies.

Authors:  Naseema Gangat; Alexandra P Wolanskyj; Susan Schwager; Ayalew Tefferi
Journal:  Eur J Haematol       Date:  2009-01-06       Impact factor: 2.997
View more
  11 in total

Review 1.  Novel and combination therapies for polycythemia vera and essential thrombocythemia: the dawn of a new era.

Authors:  Jan Philipp Bewersdorf; Amer M Zeidan
Journal:  Expert Rev Hematol       Date:  2020-11-01       Impact factor: 2.929

2.  Interferon Therapy in Myelofibrosis: Systematic Review and Meta-analysis.

Authors:  Jan Philipp Bewersdorf; Smith Giri; Rong Wang; Nikolai Podoltsev; Robert T Williams; Raajit K Rampal; Martin S Tallman; Amer M Zeidan; Maximilian Stahl
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2020-05-28

Review 3.  The role of thrombocytapheresis in the contemporary management of hyperthrombocytosis in myeloproliferative neoplasms: A case-based review.

Authors:  Prajwal Boddu; Lorenzo Falchi; Chitra Hosing; Kate Newberry; Prithviraj Bose; Srdan Verstovsek
Journal:  Leuk Res       Date:  2017-03-22       Impact factor: 3.156

Review 4.  Essential thrombocythemia treatment algorithm 2018.

Authors:  Ayalew Tefferi; Alessandro M Vannucchi; Tiziano Barbui
Journal:  Blood Cancer J       Date:  2018-01-10       Impact factor: 11.037

Review 5.  Use of Interferon Alfa in the Treatment of Myeloproliferative Neoplasms: Perspectives and Review of the Literature.

Authors:  Joan How; Gabriela Hobbs
Journal:  Cancers (Basel)       Date:  2020-07-18       Impact factor: 6.639

6.  Outcome of Pregnancy in the Era of Pegylated Interferon Alpha 2a in Females with Essential Thrombocythemia: An Experience from Qatar.

Authors:  Mohammad Abu-Tineh; Nancy Kassem; Mohammad Abdul-Jaber Abdulla; Omar Mohammad Ismail; Rola Ghasoub; Mahmood B Aldapt; Mohamed A Yassin
Journal:  Case Rep Oncol       Date:  2020-03-26

7.  Austrian recommendations for the management of essential thrombocythemia.

Authors:  Veronika Buxhofer-Ausch; Sonja Heibl; Thamer Sliwa; Christine Beham-Schmid; Dominik Wolf; Klaus Geissler; Maria Theresa Krauth; Peter Krippl; Andreas Petzer; Albert Wölfler; Thomas Melchardt; Heinz Gisslinger
Journal:  Wien Klin Wochenschr       Date:  2020-11-19       Impact factor: 1.704

8.  Association of Treatments for Myeloproliferative Neoplasms During Pregnancy With Birth Rates and Maternal Outcomes: A Systematic Review and Meta-analysis.

Authors:  Dawn Maze; Sajida Kazi; Vikas Gupta; Ann Kinga Malinowski; Rouhi Fazelzad; Prakesh S Shah; Nadine Shehata
Journal:  JAMA Netw Open       Date:  2019-10-02

Review 9.  Is there a gender effect in polycythemia vera?

Authors:  Francesca Palandri; Barbara Mora; Naseema Gangat; Lucia Catani
Journal:  Ann Hematol       Date:  2020-10-02       Impact factor: 3.673

10.  Interferon alpha therapy in essential thrombocythemia and polycythemia vera-a systematic review and meta-analysis.

Authors:  Jan Philipp Bewersdorf; Smith Giri; Rong Wang; Nikolai Podoltsev; Robert T Williams; Martin S Tallman; Raajit K Rampal; Amer M Zeidan; Maximilian Stahl
Journal:  Leukemia       Date:  2020-09-01       Impact factor: 11.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.